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Abstract
Background: The performance of multiplex PCR (mPCR) for detection of antimicrobial resistance from clinical
isolates is unknown. We assessed the ability of mPCR to analyse resistance genes directly from clinical samples.
Patients with orthopedic infections were prospectively included. Phenotypical and genotypical resistance was
evaluated in clinical samples (synovial and sonication fluid) where identical pathogens were identified by culture
and mPCR.
Result: A total of 94 samples were analysed, including 60 sonication fluid and 34 synovial fluid samples. For
coagulase-negative staphylococcus strains, mPCR detected resistance to oxacillin in 10 of 23 isolates (44%) and to
rifampin in none of 6 isolates. For S. aureus isolates, detection rate of oxacillin and rifampin-resistance was 100% (2/
2 and 1/1, respectively). Fluoroquinolone-resistance was confirmed by mPCR in all 3 isolates of Enterobacteriaceae,
in enterococci resistance to aminoglycoside-high level was detected in 1 of 3 isolates (33%) and in streptococci
resistance to macrolides/lincosamides in none of 2 isolates. The overall sensitivity for different pathogens and
antimicrobials was 46% and specificity 95%, the median concordance was 80% (range, 57–100%). Full agreement
was observed for oxacillin in S. aureus, vancomycin in enterococci, carbapenems/cephalosporins in
Enterobacteriaceae and rifampin in Cutibacterium species.
Conclusion: The overall sensitivity for detection of antimicrobial resistance by mPCR directly from clinical samples
was low. False-negative mPCR results occurred mainly in coagulase-negative staphylococci, especially for oxacillin
and rifampin. However, the specificity of mPCR was high and a positive result reliably predicted antimicrobial
resistance. Including universal primers in the PCR test assay may improve the detection rate but requires additional
sequencing step.
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Background
An interdisciplinary approach including surgical and
antimicrobial treatment is crucial to eradicate bone and
joint infection, including periprosthetic joint infections
(PJI) and infections after internal bone fixation [1].
Treatment strategies are guided by the type of causative
pathogen and its antimicrobial susceptibility, with special
focus on biofilm-active antibiotics [2].
Previous studies demonstrated limited sensitivity of
periprosthetic tissue culture (45–71%) and synovial fluid
culture (52–64%) for microbial detection [3–8]. Cultures
remain negative in particular in low- burden, chronic
low-grade infections or in case of preceding antimicro-
bial therapy [9, 10]. Moreover, phenotypical antimicro-
bial testing using conventional cultures requires several
days in mixed infections and if slow-growing microor-
ganisms are involved. Therefore, new techniques were
developed to improve the diagnostic yield, such as sonic-
ation of retrieved implants and broad-range PCR of son-
ication fluid, improving sensitivities to 73–89% [3, 4, 10,
11]. In a further study, inoculation of sonication fluid
into blood culture bottles further improved the diagnosis
of orthopaedic implant-associated infections and re-
duced the time to culture positivity [12].
The value of multiplex PCR (mPCR) in synovial fluid,
periprosthetic tissue and sonication fluid has been re-
cently extensively investigated [6, 13–18]. Advantages of
the mPCR technique are rapid identification of the
causative pathogen and potentially detection of genetic
markers for clinically relevant antimicrobial resistances
[18]. However, limited data exists on the performance of
mPCR for the detection of antimicrobial resistance
markers in the clinical setting.
In this study, we assessed the value of a commercial
mPCR assay (Unyvero i60 ITI) in genotypical detection
of antimicrobial resistance, considering conventional
culture the gold standard. In addition, we evaluated the
concordance of susceptibility test results deriving from




Ninety-four samples of 82 patients with a median age of
75 years (range, 28–98 years) were analysed, 47 patients
(57%) were female. The 60 sonication fluid samples orig-
inated from 38 infected prostheses (20 knee, 15 hip, 2
shoulder, and 1 elbow prosthesis) and 22 osteosyntheses
(localized in the spine in 9 patients, tibia in 6, ankle in 2,
femur in 2, humerus in 1, clavicle in 1, and elbow in 1
patient). The 34 synovial fluids were harvested from 31
infected prosthetic (13 knees and 18 hips) and 3 native
septic joints (two knee and one hip joint).
Microbiological characteristics
The detected pathogens in sonication and synovial fluid
samples are summarized in Table 1. The most frequently
isolated pathogens were Staphylococcus spp. (52%),
followed by Enterobacteriaceae (15%) and Streptococcus
agalactiae (12%). Eighty-five monomicrobial and 9 poly-
microbial infections were observed. In 12 patients, both
sonication and synovial fluid were analysed and yielded
the identical pathogen.
Performance of resistance gene detection and its
concordance with phenotypical resistance testing
The detection rate of vancomycin resistance by mPCR in
Enterococcus spp. could not be assessed as no resistance
was detected by conventional culture. The same applies
for Enterobacteriaceae and aminoglycosides, carbapenems,
third-generation cephalosporins, as well as for Cutibacter-
ium spp. and rifampin.
Performance of mPCR and concordance of phenotyp-
ical and genotypical susceptibility testing is summarized
in Table 2 (Additional file 1). Overall, a median sensitiv-
ity of 46% and specificity of 95% was shown, with a me-
dian concordance of 80%. There was no difference seen
regarding number of discordant pairs comparing syn-
ovial and sonication fluid.
Staphylococcus spp
Among Staphylococcus spp. isolates, concordance of
phenotypical and genotypical susceptibility to oxacillin,
aminoglycosides, macrolides/lincosamides and rifampin
was 72, 73, 73 and 84%, respectively. The mPCR detected
oxacillin resistance genes in 10 of 23 samples associated
with oxacillin-resistant coagulase-negative staphylococci
positive cultures (44%), whereas both oxacillin-resistant S.
aureus strains detected by culture were found to be resist-
ant by mPCR (sensitivity 100%). In coagulase-negative
staphylococci, none of the rifampin resistance determined
by culture was detected by mPCR; in S. aureus isolates,
one true positive and one false negative rifampin
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resistance was detected by mPCR, resulting in a NPV of
100% and a PPV of 50%.
Enterococcus spp
The vancomycin antimicrobial resistance testing showed
100% agreement in 10 isolates (all tested susceptible).
Among 7 tested strains, one isolate was tested resistant
to aminoglycosides with both methods. Genotypical
high-level resistance to aminoglycosides was determined
in 1 sample, whereas phenotypical resistance was deter-
mined by culture in 3 isolates. Thus, mPCR missed the
resistance to aminoglycosides detected through aac(6′)/
aph(2″) in 2 samples (66%). The resulting concordance
was 71% with a sensitivity, specificity, NPV and PPV of
33, 100, 67 and 100%, respectively.
Enterobacteriaceae
The overall agreement for the testing of different anti-
microbial agents in 14 Enterobacteriaceae isolates was
good with mPCR test results showing NPV of 100% for
all antimicrobial agents. mPCR detected resistance to
fluoroquinolones in all 3 isolates. False-positive resist-
ance was detected for aminoglycosides in 4 patients,
resulting in a PPV of 0% and for fluoroquinolones in 1
patient with a PPV of 75%.
Streptococcus spp
Of 10 Streptococcus agalactiae isolates, lincosamides by
culture/lincosamides by culture and ten by mPCR,
resulting in a concordance and NPV of 80% and a speci-
ficity of 100%. As no resistant strain was detected, PPV
could not be assessed.
Anaerobes
For rifampin, all 6 isolates of Cutibacterium spp. showed
concordance (susceptibility by culture and mPCR). In one
sonication fluid sample, Finegoldia magna was identified
by culture and mPCR. This pathogen was susceptible to
amoxicillin/clavulanic acid, penicillin, piperacillin/tazobac-
tam, imipenem, clindamycin, rifampin and levofloxacin by
conventional susceptibility testing using culture. However,
no markers are available for resistance testing for this
pathogen using the mPCR system.
Discussion
Rapid identification of a pathogen and its susceptibility
pattern allows effective optimization of the antimicrobial
treatment and prevention of emergence of resistance.
While conventional culture is the gold-standard microbio-
logical method, molecular methods are increasingly used
in the clinical routine. However, limitations of molecular
detection of drug-resistance genes need to be considered,
in particular the fact that genotypic drug-resistance identi-
fication does not conclusively corresponds to the pheno-
type [19]. In addition, focusing on the detection of a
certain selection of genes with mPCR, the diversity of all
bacterial resistance genes is not represented.
The sensitivity and specificity of mPCR for pathogen
detection directly from clinical samples found in the
published sub-cohorts ranged in sonication fluid from
51 to 71% and 92 to 94%, respectively, and in synovial
fluid from 23 to 60% and 89 to 91%, respectively [6–8,
17]. Previous publications using mPCR for pathogen
identification reported similar sensitivities ranging from
51 to 96% and specificities from 94 to 100% [13, 16, 18,
20, 21]. However, limited data exists on the performance
of the mPCR system for detection of resistance genes
and their agreement on conventional antimicrobial sus-
ceptibility testing in patients with bone and joint infec-
tions [18, 22].
A recent study [23] employing the first generation of
the multiplex PCR device reported a low detection rate
(6%) of mecA and mecC genes in methicillin-resistant
staphylococci (not specified which subspecies), which
Table 1 Distribution of detected pathogens
Microbiology Sonication fluid (n = 60) Synovial fluid (n = 34) Total (n = 94)
Coagulase-negative staphylococci 21 12 33 (35%)
Staphylococcus aureus 9 7 16 (17%)
Streptococcus agalactiae 4 7 11 (12%)
Enterococcus spp.a 8 2 10 (11%)
Escherichia coli 4 5 9 (10%)
Cutibacterium spp.b 8 1 9 (10%)
Enterobacter cloacae 3 0 3 (3%)
Finegoldia magna 1 0 1 (1%)
Proteus spp. 1 0 1 (1%)
Klebsiella pneumoniae 1 0 1 (1%)
aIncluding 9 isolates of E. faecalis and 1 isolate of E. faecium
bIncluding 8 isolates of C. acnes and 1 isolate of C. avidum
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increased to 35% when using the second generation of
the mPCR cartridge. In our cohort, we observed a detec-
tion rate of 48% (12 of 25 isolates) for oxacillin resist-
ance. However, the oxacillin-resistance detection rate in
S. aureus was considerably higher than in coagulase-
negative staphylococci (100% versus 44%). The limited
detection of oxacillin resistance in coagulase-negative
staphylococci by mPCR may be explained by the low mi-
crobial burden usually seen in low grade infections
caused by less virulent staphylococci, which probably
does not reach the detection limit of the mPCR system
of mecA and mecC, estimated at ~ 104 and ~ 106 DNA
copies/ml, respectively. This hypothesis is corroborated
by the fact, that the concordance in infections caused by
S. aureus – usually acute infections - was considerably
higher. Furthermore, a great diversity of the staphylococcal
cassette chromosome mec in coagulase-negative staphylo-
cocci may contribute to a reduced detection rate of oxacil-
lin resistance [24].
From the clinical viewpoint, susceptibility to rifampin is
of paramount relevance in implant-associated infections
caused by staphylococci and Cutibacterium spp., as this
antibiotic is the only biofilm-active antibiotic for these mi-
croorganisms [25, 26]. Pre-operative knowledge of rifam-
pin resistance influences the surgical decision, as a lack of
biofilm-active treatment usually discourages retention of
the implant in acute infections and a one-stage exchange
in chronic infections [1]. In our cohort, the concordance
between genotypical and phenotypical evaluation for ri-
fampin was moderate for Staphylococcus spp. (84%) with
86% false-negative test-result (i.e. phenotypically resistant
and genotypically susceptible) and excellent for Cutibac-
terium spp. (100%). However, the cartridge is not validated
for rifampin susceptibility testing in Cutibacterium spp.
and coagulase-negative staphylococci. When analysing S.
aureus only, for which the system is validated, a concord-
ance of 93% with a negative predictive value of 100% was
obtained. Similarly, fluoroquinolones represent the
biofilm-active agent for implant-associated infections
caused by gram-negative bacteria [27]. For all analysed E.
coli strains, a concordance of 89% for fluoroquinolones
with a 100% NPV was detected.
With 71 to 73%, the concordance of phenotypical and
genotypical testing for aminoglycosides was in the lower
range for all tested pathogens, i.e. staphylococci, entero-
cocci and gram-negative rods. For enterococci and
streptococci, the NPV was low due to missed resistance
by mPCR. In contrast, in gram-negative rods false-
positive mPCR test resulted in low PPV (0%).
We acknowledge several limitations of this study. First,
given the low number of rifampin-resistant staphylococci
and fluoroquinolone-resistant Enterobacteriaceae, its
value for detection of pathogens causing difficult-to-
treat infections is limited and their predictive values
from our study should be taken with caution. Addition-
ally, we could not assess detection rates for several re-
sistance genes, as we did not include any isolates tested
resistant by conventional culture (e.g. gram-negative ba-
cilli resistant to aminoglycosides, third generation cepha-
losporines and carbapenems). Another limitation
represents the inclusion of exclusively those clinical
samples, which were concordant in pathogen detection
by culture and mPCR. The performance of mPCR in dis-
cordant samples is unknown and the specificity results
of this study may be overestimated. Furthermore, we
have not investigated the performance of mPCR in viable
but non culturable (VBNC) condition, where the num-
ber of DNA copies may be much lower than that in
growing condition. Finally, an analysis between the
quantitative MIC values (i.e., strength of resistance) and
detectability of resistance genes (i.e., numbers of DNA
copies) was not performed in our study, which
might provide additional insights in the performance of
mPCR for detection of antimicrobial resistance.
Conclusion
The overall sensitivity for detection of antimicrobial re-
sistance by mPCR directly from clinical samples was
low. Due to low sensitivity the evaluated commercial
mPCR system cannot replace conventional antimicrobial
resistance testing. False-negative mPCR results occurred
mainly in coagulase-negative staphylococci, especially for
oxacillin and rifampin. However, the specificity of mPCR
was high and a positive result reliably predicts resistance
and for some pathogens and antibiotics full agreement
was observed, including for oxacillin in S. aureus, vanco-
mycin in enterococci, carbapenems/cephalosporins in
Enterobacteriaceae and rifampin in Cutibacterium spe-
cies. Including universal primers in the PCR test assay




This prospective single-center study (public clinical trial
identification at www.clinicaltrials.gov NCT02530229)
was conducted in accordance with the Declaration of
Helsinki. Approval of the institutional review board was
obtained (EA1/306/14) and patients provided written in-
formed consent before study inclusion. The results of
mPCR were not used to guide antimicrobial therapy.
Data analysed in this study represent a subpopulation of
previously published cohorts analysing the performance
of mPCR with regards to detection of bacteria in syn-
ovial fluid of native joints [7] and periprosthetic joints
[17], as well as in sonication fluid from removed joint
prostheses [6] and other orthopaedic hardware [8].
Among 378 samples (179 sonication fluids [128
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prostheses, 51 osteosyntheses], 199 synovial fluids [142
prosthetic joints, 57 native joints]) enrolled in the above-
mentioned published cohort studies, 94 samples de-
tected the same microorganisms using mPCR and con-
ventional culture. Two-hundred-nine specimens with no
microbial growth, 73 patients with discordant microor-
ganisms and two cases, where no phenotypical drug re-
sistance analysis was performed, were excluded. A study
selection flow diagram is shown in Fig. 1.
Study population
Consecutive adult patients who had undergone diagnos-
tic joint aspiration for suspected septic arthritis or revi-
sion surgery for implant-associated bone infection
between November 2014 and October 2015 were in-
cluded. Four patients in whom sonication fluid of re-
trieved osteosynthesis was investigated, were receiving
antimicrobial treatment at time of explantation. No
other patients had been pre-treated with antibiotics.
Joint aspiration
Synovial fluid was aspirated by an orthopaedic surgeon
according to standardized aseptic technique. After skin
preparation, synovial fluid was collected using a sterile
18-gauge spinal needle and a 10-ml syringe. If no syn-
ovial fluid was obtained, the needle was repositioned
without withdrawing it through the skin.
Synovial fluid cultures
0.1 milliliter of synovial fluid was inoculated onto aer-
obic and anaerobic plates (sheep blood agar, chocolate
agar, and Schädler anaerobic agar), and 1 ml was inocu-
lated in thioglycolate broth. Agar plates were incubated
at 37 °C under aerobic and anaerobic conditions for 14
days and inspected daily for microbial growth. Microbial
identification was performed using Vitek2 (bioMérieux,
Nürtingen, Germany) or a matrix-associated laser de-
sorption/ionization-time of flight mass spectrometer
(bioMérieux). The antimicrobial susceptibility testing
was conducted using Vitek2 and the minimum inhibi-
tory concentration (MIC) values were determined and
interpreted according to EUCAST standards. For mPCR
analysis, 2–5 ml of the synovial or 10–50 ml of sonic-
ation fluid was transferred to a sterile vial and stored at
− 80 °C until processing.
Fig. 1 Study selection flow diagram
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Removal and transport of orthopedic hardware
The joint prosthesis components (metal, ceramic or
polyethylene parts) or other fracture fixation devices
(plates, nails or screws) were removed in the operating
room. After removal, the hardware components were
transported to the microbiological laboratory in a sterile
air-tight container (Lock&Lock, Frankfurt am Main,
Germany) and processed within 6 hours.
Sonication procedure
In the microbiology laboratory, normal saline was added
to the container, covering at least 80% of the hardware.
The container was vortexed for 30 s and sonicated for 1
minute at 40 kHz and 0.2W/cm2 (BactoSonic, Bandelin
electronic, Berlin, Germany). Additional vortexing was
conducted for 30 s before the sonication fluid was plated.
Then, 0.1 ml of the sonication fluid was inoculated onto
agar plates and 1ml was inoculated in thioglycolate
broth. Microorganisms were enumerated (i.e. number
of colony-forming unit [CFU]/ml sonication fluid).
Microbial identification and antimicrobial susceptibil-
ity testing were performed as described above for syn-
ovial fluid.
Multiplex PCR analysis
The Unyvero i60 ITI application (Unyvero i60, Curetis,
Holzgerlingen, Germany, second generation), designed for
a semi-quantitative DNA determination parallelly per-
forming eight multiplex PCR reactions, was used. This in-
strument is capable to detect 114 nucleic acids and 20
drug resistance markers. Fifty milliliter of the sonication
fluid were first centrifuged at 4000 x g at 4 °C for 20min
(Microcentrifuge 5427R, Eppendorf, Wesseling-Berzdorf,
Germany). The supernatant was discarded and 180 μl of
the pellet were further processed. The synovial fluid was
processed directly without centrifugation. The Unyvero
i60 ITI application was used according to the manufac-
turer’s protocol. In brief, the pre-treated sample was
treated with proteinase K for 30min, master mix was
added and inserted into the Unyvero ITI Cartridge. The
cartridge device is equipped with eight separate chambers,
a corresponding number of arrays, reagent containers and
a DNA purification column. The assembled and closed
Unyvero ITI Cartridge was inserted into the Unyvero
Analyzer, which then automatically processed the sample
within 5 hours. The microbial identification and antibiotic
resistance markers are displayed on the screen of the in-
strument. A sample was considered positive if at least one
of the analytes (pathogens) reached the threshold of 104
DNA copies/ml.
According to the manufacturer, the resistance markers
aacA4, ctx-M, ermA, gyrA83, mecA, vanA and the beta-
lactamase genes blandm, blaoxa-23, blaoxa-48, blaoxa-58 were
detected at a concentration of 104 DNA copies/ml; the
resistance markers aac(6′)/aph(2″), gyrA87, blaimp,
blakpc, blaoxa-24, and blavim were detected at a concentra-
tion of 105 DNA copies/ml; and the resistance markers
ermC, mecC, rpoB, and vanB at a concentration of 106
DNA copies/ml. The range of antibiotic resistance genes
detected with the mPCR system is shown in Table 3.
Statistical analysis
Categorical variables are described as absolute frequen-
cies and percentages. Metrical variables are expressed by
median and range, as appropriate. The performance of
mPCR (i.e. sensitivity and specificity) and its positive
predictive value (PPV) and negative predictive value
(NPV) were assessed in terms of detection of resistance,
using phenotypical testing by conventional culture as
gold standard. Concordance analysis was performed
comparing phenotypical and genotypical resistance test
results, for substances, for which genotypical resistance
markers were included in the mPCR cartridge. The soft-
ware packages XLSTATPM (version 2017; XLSTAT;
Addinsoft, New York, NY, USA).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12866-020-01741-7.
Additional file 1. Raw data of the concordant microorganisms and their
detected resistances by mPCR and culture.
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Carbapenems blavim, blaimp, blakpc, blandm, blaoxa-23,
blaoxa-24, blaoxa-48, blaoxa-58
Fluoroquinolonesb gyrA83, gyrA87
aRifampin resistance testing is only validated for Staphylococcus aureus
bFluoroquinolone resistance testing is only validated for Escherichia coli among
gram-negative bacteria
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